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The central nervous system (CNS) plays key role in the homeostatic regulation of body weight. Satiation and
adiposity signals, providing acute and chronic information about available fuel, are produced in the periphery
and act in the brain to influence energy intake and expenditure, resulting in the maintenance of stable
adiposity. Diet-induced obesity (DIO) does not result from a failure of these central homeostatic circuits.
Rather, the threshold for defended adiposity is increased in environments providing ubiquitous access to
palatable, high-fat foods, making it difficult to achieve and maintain weight loss. Consequently, mechanisms
by which nutritional environments interact with central homeostatic circuits to influence the threshold for
defended adiposity represent critical targets for therapeutic intervention.Energy balance relies on a tightly regulated homeostatic system
matching energy intake with energy expenditure in order to
maintain a stable body weight. In other words, body weight,
and specifically body fat, is normally defended against acute
perturbations. For example, animals that are calorically restricted
to produce substantial weight loss quickly rebound when
returned to ad libitum feeding, recovering their initial bodyweight
within days (Levin and Keesey, 1998; Woods et al., 2003). Analo-
gously, animals chronically overfed via an intragastric catheter
quickly shed the excess weight gain by reducing their daily
food intake when overfeeding stops (Hagan et al., 1999; Seeley
et al., 1996a). Similarly, humans subjected to experimental
weight loss or weight gain adjust their food intake and/or energy
expenditure in order to defend baseline adiposity (Leibel et al.,
1995; Roberts et al., 1990; Sims, 1976). Consequently, most
adults, even those who are overweight or obese, maintain a rela-
tively stable body weight when measured over long intervals.
In a recent longitudinal study, for example, men with no history
of obesity gained an average of only 0.18 kg$bw/year, and an
age-matched obese group gained just 0.04 kg$bw/year (Van
Wye et al., 2007), illustrating the remarkably precise nature of
the homeostatic system regulating adiposity.
The central nervous system (CNS) plays a key role to balance
the energy equation. Environmental and internal signals, indi-
cating energy needs and availability, are integrated in CNS
circuits. These recruit appropriate effector systems to adjust
behavioral and physiological responses, maintaining adiposity
at a relatively constant level. Considerable progress has been
made to elucidate the molecular and cellular pathways, primarily
within the hypothalamus and hindbrain, comprising these
circuits. An emergent principle of this homeostatic regulation is
that acute satiation signals, arising in the gastrointestinal system
(GI) and secreted phasically during meals, are integrated with
more tonically active adiposity signals to adjust nutrient intake
and energy expenditure.Satiation signals induce feelings of fullness and influence the
decision to stop eating (Woods and D’Alessio, 2008). Many sati-
ation signals are peptides secreted from enteroendocrine cells
in the wall of the GI tract. They stimulate adjacent sensory
nerves, forwarding information to the hindbrain to initiate appro-
priate reflexes, and influence the decision to keep eating or to
end the meal. When administered peripherally at the start
a meal, satiation signals result in less food being eaten (Fujimoto
et al., 1993; Gibbs and Smith, 1977; Ru¨ttimann et al., 2009). The
response is dose dependent and short lived. Conversely,
administration of antagonists to satiation signals results in
larger meals being eaten, indicating that endogenous satiation
signals normally limit meal size (Hewson et al., 1988; Williams
et al., 2009). Several satiation signals have been identified,
including cholecystokinin (CCK), glucagon-like peptide (GLP-1),
glucagon, oxyntomodulin, peptide tyrosine-tyrosine (PYY),
apolipoprotein A-IV, enterostatin, amylin, and members of the
bombesin family of peptides (Moran, 2004; Woods and
D’Alessio, 2008). The various satiation signals respond with
differing sensitivity to diverse physicochemical stimuli created
by the meal, including individual nutrients, to limit meal size.
Whereas satiation signals reflect the nutrient and caloric
content of a meal, adiposity signals reflect the amount of stored
body fat. The most-studied adiposity signals are insulin and
leptin. Insulin is secreted from the pancreatic b-cells, and leptin
is secreted from adipocytes, both in direct proportion to total
adiposity (Bagdade et al., 1967; Frederich et al., 1995; Polonsky
et al., 1988; Schwartz et al., 1996), providing reliable indicators of
stored energy. Insulin and leptin are transported from the circu-
lation into the brain. In lean individuals, increased flux of insulin or
leptin stimulates receptors in the hypothalamus and in other
brain regions to reduce food intake (Brief and Davis, 1984;
Halaas et al., 1995; Seeley et al., 1996b; Woods et al., 1979).
Conversely, experimentally reducing adiposity signaling in the
brain results in hyperphagia and weight gain (Bru¨ning et al.,Cell Metabolism 15, February 8, 2012 ª2012 Elsevier Inc. 137
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Figure 1. Homeostatic Regulation of Energy Balance Is Maintained
in Diet-Induced Obesity
Both obese rats maintained on a high-butter-fat diet (HFD, squares) and lean
rats maintained on either low-butter-fat diet (LFD) or standard chow (triangles),
defend their body weight against acute perturbations. Rats were calorically
restricted in order to produce a 12% weight loss. When returned to ad libitum
feeding, all groups recovered to their initial body weight within a similar time
frame. Adapted from Woods et al. (2003).
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signals, adiposity signals have long-lasting effects that span
several meals or days, stabilizing adipose stores.
Satiation and adiposity signals interact synergistically to influ-
ence energy intake and expenditure. Leptin and insulin signaling
provide a background tone that determines sensitivity to satia-
tion signals. For example, individuals that diet and lose fat
secrete less leptin and insulin and consequently have reduced
leptin and insulin signaling in the brain. This lowers sensitivity
to satiation signals including CCK (Emond et al., 2001; Matson
et al., 2000). The result is that larger-than-normal meals are
eaten. Conversely, when individuals acutely gain excess fat,
leptin and insulin signaling in the CNS is elevated, enhancing
sensitivity to satiation signals (Riedy et al., 1995; Williams et al.,
2006). Thus, adiposity and satiation signals interact in a manner
that facilitates the defense of stable adipose stores.
The Obesity Epidemic
Despite this robust homeostatic system, the world is in the midst
of an obesity crisis. The National Health Examination Studies
and the National Health and Nutrition Examination Studies, con-
ducted regularly beginning in 1960, indicate that body weight of
adult Americans was relatively stable between 1960 and 1980,
with approximately 25% of the population being classified as
overweight or obese (Kuczmarski et al., 1994). Since then, this
proportion has dramatically increased, and the Centers for
Disease Control now estimates that more than 68% of adults
in the United States are overweight or obese. These sobering
statistics beg the question of, if the central homeostatic system
governing energy balance is so precise, then why are popula-
tions becoming obese?
Although there is clearly a heritable component to an individ-
ual’s susceptibility to becoming overweight, the short time frame
in which our collective waistlines have expanded implies that
a change in gene frequencies is unlikely to be the primary caus-
ative factor. Rather, the increased incidence of obesity is thought
to reflect an interaction between our genotype and an increas-138 Cell Metabolism 15, February 8, 2012 ª2012 Elsevier Inc.ingly obesogenic environment. Among the numerous possible
environmental factors that may contribute to obesity, ubiquitous
access to low-cost, calorically dense foods, and especially those
high in fat content, is considered among the most important.
Individuals fed a diet containing a high proportion of fat as
calories tend to become obese. We and others have often
referred to this high-fat diet-induced obesity (often referred to
as DIO) as a dysregulation or failure of energy homeostasis.
However, this characterization obscures the fact that obese indi-
viduals typically maintain a relatively stable body weight, and
robustly defend their higher level of adiposity. Similar to lean
animals, for example, DIO rats that are calorically restricted to
produce a substantial weight loss quickly rebound when re-
turned to ad libitum feeding and fully recover their initial body
weight within the same time frame as lean controls (Levin and
Dunn-Meynell, 2000; Woods et al., 2003) (Figure 1). This defense
of excess body fat is also familiar to humans, as illustrated by the
discouraging phenomenon of yo-yo dieting, in which weight loss
achieved by vigilant diet and/or exercise is regained when the
vigilance is softened (Kramer et al., 1989; Leibel et al., 1995).
Weight loss achieved by pharmacological interventions is also
susceptible to weight regain upon removal of the intervention.
The important point is that the integrity of the homeostatic
system appears to be maintained in DIO (Morton et al., 2006)
and may in fact contribute to the maintenance of obesity.
Consequently, DIO probably does not reflect a state of ‘‘dys-
regulated’’ energy balance. Rather, we suggest that the de-
fended level of adiposity is a plastic phenotype that varies along
a norm of reaction, within limits defined by genetic and/or
epigenetic parameters, according to changing physiological
and environmental conditions (e.g., Ghalambor et al., 2007).
This concept is consistent with the observation that adipocytes
themselves are also remarkably plastic in terms of the amount
of stored fat they can accommodate (Sethi and Vidal-Puig,
2007), providing a buffer against acute changes in nutrient
load. In a similar way, we suggest that plasticity in defended
levels of adiposity can buffer against stochastic environmental
conditions, including changes in the spatial or temporal avail-
ability of macronutrients. Given the historically transient avail-
ability of fat-rich food sources, individuals that defend higher
levels of adiposity when faced with nutrient abundance should
have greater fitness compared to conspecifics that exhibit less
phenotypic plasticity (as in Neel, 1962). This would result in
selection for pathways that couple the availability of ephemeral
nutrients with hyperphagia and increased fat storage. Within
this framework, it will be informative to ask how dietary fatsmight
interact with central homeostatic circuits to shift the defended
level of adiposity, as these mechanisms represent important
nodes for therapeutic intervention. This is the topic of the current
review.
Reduced Sensitivity to the Adiposity Signals Insulin
and Leptin
One mechanism by which an ecological abundance of dietary
fats might increase the defended level of adiposity is by reducing
responsivity to the adiposity hormones leptin and insulin.
Consistent with this, obese individuals maintain higher plasma
leptin levels in proportion to their greater adiposity, suggesting
reduced responsivity to its catabolic action (Frederich et al.,
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Figure 2. Diet-Induced Leptin and Insulin Resistance Facilitate
Defense of Greater Adiposity
Plasma concentrations of the adiposity signals leptin and insulin increase in
proportion to increased adiposity. However, the threshold plasma concen-
tration at which CNS leptin or insulin action indicates appropriate fat storage
(red dashed lines) is increased, such that higher concentrations are needed to
elicit an anorectic response, and greater adiposity is defended. Resistance to
adiposity hormones can be conceptualized as the difference between these
thresholds (blue line).
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to the behavioral and cellular actions of exogenously adminis-
tered leptin. Administration of leptin directly into the CNS of
DIO rats (Scarpace et al., 2001; Widdowson et al., 1997) and
mice (El-Haschimi et al., 2000) does not reduce food intake
and likewise fails to activate the JAK/STAT (El-Haschimi et al.,
2000;Mu¨nzberg et al., 2004) and S6K (Cota et al., 2008) signaling
pathways that are downstream of the leptin receptor and impor-
tant for its catabolic action. Similarly, DIO animals maintain
higher plasma insulin levels in proportion to their level of body
fat (Bagdade et al., 1967) but exhibit a blunted anorectic
response to the administration of exogenous insulin into the
brain (Arase et al., 1988; Chavez et al., 1995; Clegg et al.,
2005). Activation of PI3K downstream of the insulin receptor is
blunted in DIO (De Souza et al., 2005; Posey et al., 2009).
Reduced leptin and insulin signaling in obese individuals would
limit the capacity to increase sensitivity to satiation signals,
thereby allowing larger meal size and facilitating the defense of
greater adiposity (Figure 2) (Myers et al., 2010). Although we
hereafter follow convention by using the term leptin/insulin resis-
tance to describe these blunted behavioral and/or cellular
responses to adiposity signals, we interpret this as a regulated
process, not the dysfunctional phenomenon that the word
‘‘resistance’’ might imply. Specific mechanisms tying the avail-
ability of HFD to the development and maintenance of leptin/
insulin resistance represent important therapeutic targets, and
have been the focus of intense research by various groups.
Molecular Lipid Sensors as Modulators of Leptin
and Insulin Sensitivity
PKC-q
The serine-threonine protein kinase C-q (PKC-q) is a hypotha-
lamic lipid-sensing protein thought to provide a mechanism link-
ing dietary fats to the development of obesity. Members of the
novel class of PKC isoforms, including PKC-q, bind and are acti-
vated by intracellular diacylglycerols (DAGs), which accumulate
when fatty-acid delivery to the cell outpaces the rates of fatoxidation and triglyceride synthesis (Erion and Shulman, 2010),
and this is associated with blunted insulin signaling in peripheral
tissues (e.g., Griffin et al., 1999). PKC-q is also expressed in the
medial-basal hypothalamus (Benoit et al., 2009; Dewing et al.,
2008), where accumulation of long-chain fatty acyl CoAs and
DAGs is increased in rats chronically maintained on a diet high
in saturated fats, rats receiving an acute gavage of saturated
fats, and rats receiving infusions of palmitate directly into the
brain (Figure 3) (Benoit et al., 2009). In keeping with this, activa-
tion of hypothalamic PKC-q is likewise increased in these treat-
ments and is associated with a blunted anorectic response to
central insulin. Conversely, insulin sensitivity is restored to DIO
rats by virally mediated knockdown of PKC-q in the medial-basal
hypothalamus, implicating increased hypothalamic DAG accu-
mulation and activation of PKC-q in diet-induced CNS insulin
resistance (Benoit et al., 2009).
Peroxisome Proliferator-Activated Receptors
The peroxisome proliferator-activated receptors (PPARs),
another class of lipid sensors that may link maintenance on
a high-fat diet (HFD) with obesity, are nuclear receptors activated
by intracellular lipids to regulate gene expression. The PPARg
isoform, for example, is highly expressed in adipocytes, where
it is a master regulator of adipogenesis (Patel et al., 2003; Rosen
et al., 1999; Tontonoz et al., 1994) and lipogenesis (Lehrke and
Lazar, 2005; Patel et al., 2003), thereby coupling the availability
of fatty acids with increased fat synthesis and triglyceride
storage. PPARg is also expressed in key hypothalamic sites
known to be important for the regulation of energy balance
(Mouihate et al., 2004; Sarruf et al., 2008). We (Ryan et al.,
2011) and others (Lu et al., 2011) have found that activation of
CNS PPARg, likely in the hypothalamus, leads to increased
food intake and body fat. Reduction of the activity of CNSPPARg
by local administration of a specific antagonist (Ryan et al., 2011)
or with neuron-specific gene deletion (Lu et al., 2011) leads to
acute and chronic reductions in HFD intake and blunts weight
gain associated with HF feeding. However, no differences are
observed when rodents are maintained on a low-fat diet (Lu
et al., 2011; Ryan et al., 2011; Sarruf et al., 2008), indicating
that increased activation of CNS PPARg under conditions of
HF feeding contributes to the development and maintenance
of a higher body weight. CNS PPARg also contributes to leptin
resistance. Reducing the activity of CNS PPARg in HFD-fed
rats by central administration of its antagonist, or in mice by
neuron-specific genetic knockdown of PPARg, maintains the
anorectic response to exogenous leptin in DIO animals (Ryan
et al., 2011) and likewise accentuates leptin-induced STAT3
signaling (Lu et al., 2011). Together, these data indicate that acti-
vation of hypothalamic PPARg by increased flux of fatty acids
results in leptin resistance that facilitates the development and
maintenance of DIO (Figure 3). However, important questions
remain. With respect to PPARg, the key hypothalamic target
genes are unknown, and it is not clear which cellular and molec-
ular mechanisms link the PPARg and leptin signaling pathways.
Moreover, other lipid-sensing PPAR isoforms are also expressed
in hypothalamus, where they may also modulate food intake and
body weight (Chakravarthy et al., 2007; Moreno et al., 2004).
Chakravarthy et al. (2007), for example, reported that activation
of hypothalamic PPARa, by endogenous products of fatty-acid
synthase, increases food intake. Less is known, however, aboutCell Metabolism 15, February 8, 2012 ª2012 Elsevier Inc. 139
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Figure 3. Nutrient-Sensing Mechanisms Contributing to Diet-Induced Leptin and Insulin Resistance
Excess lipid flux into the central nervous system leads to activation of nutrient-sensing pathways in the hypothalamus, including PKCq, PPARg, ER stress, and
inflammatory mediators. Activation of these pathways results in blunted cellular responses to circulating leptin and insulin, including changes in transcriptional
activity and/or neuronal firing. Consequently, higher plasma concentrations of leptin and insulin are needed to induce downstream effectors. Body fat stores are
increased until this new threshold is reached.
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will be necessary to address these key questions.
The Innate Immune Response
Recent attention has focused on the role of chronic, low-grade
activation of the innate immune system in the pathogenesis of
DIO and its associated comorbidities. The toll-like receptor 4
(TLR4), a type-I transmembrane receptor that recognizes lipo-
polysaccharide (LPS), a lipid derived from bacterial cell walls,
is a key player in the innate immune response. Upon binding
by LPS, TLR4 activates pathways either dependent or indepen-
dent of the adaptor molecule, myeloid-differentiation primary-
response gene 88 (MyD88). The MyD88-dependent pathway
activates mitogen-activated protein kinases (MAPKs) and
c-Jun N-terminal kinase (JNK), leading to activation of the tran-
scription factor Activator protein-1 (AP-1). The MyD88-depen-
dent pathway also activates inhibitor-of-kB kinase-b (IKKb),
leading to activation of the transcription factor nuclear-factor-
kB (NF-kB). In this way, increased TLR4 activity leads to the in-
creased production of several inflammatory cytokines, including140 Cell Metabolism 15, February 8, 2012 ª2012 Elsevier Inc.interleukins -1b and -6 (IL-1b and IL-6) and tumor-necrosis
factor-a (TNFa). The MyD88-independent pathway activates
the transcription factor interferon-regulatory factor 3 (IRF-3),
increasing interferon-b (IFN- b) as well as other chemokines
(Akira and Takeda, 2004; Kawai and Akira, 2010; Milanski
et al., 2009; Selvarajoo, 2006). In response to infection, this coor-
dinated response leads to fever and other appropriate physio-
logical responses. Among these is reduced insulin sensitivity in
muscle, liver, and adipose tissue, associated with greater lipid
and glucose availability to fuel energetically demanding immune
responses (Grimble, 2002; Wellen and Hotamisligil, 2005).
In addition to providing the nonspecific response to patho-
gens, the innate immune system also exhibits low-level chronic
activity associated with obesity and the metabolic syndrome.
In both humans and rodents, plasma markers of inflammation
are significantly associated with body mass index, serum
triglycerides, and systemic insulin resistance (Chan et al.,
2002; Duncan and Schmidt, 2001; Pickup and Crook, 1998).
Consistent with this, adipose tissue itself produces a wide range
of proinflammatory cytokines and acute-phase reactants,
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systemic inflammation associated with increased adiposity in
obese individuals (Hotamisligil, 2005; Rajala and Scherer,
2003; Uysal et al., 1997). It is now recognized that chronic low-
grade systemic inflammation contributes to the increased risk
of peripheral insulin resistance associated with obesity (Donath
and Shoelson, 2011). One consequence has been attempts to
use anti-inflammatory agents to treat type-2 diabetes mellitus
(Fleischman et al., 2008; Goldfine et al., 2008; Larsen et al.,
2007).
Consumption of a HFD also initiates a proinflammatory
response in the hypothalamus. DeSouza et al. (2005) evaluated
the effect of consuming a HFD on hypothalamic gene expres-
sion. Messenger RNAs (mRNAs) for immune-related proteins
were the largest group modulated by diet, and this was
confirmed by increased protein expression of IL-1b, IL-6, and
TNFa locally in the hypothalamus. Moreover, HF-fed rats had
increased activation of two inflammatory pathways upstream
of cytokine production, JNK and NF-kB. Consistent with other
reports (Arase et al., 1988; Chavez et al., 1995; Clegg et al.,
2005), HF-fed rats were resistant to the anorectic effects of
central insulin. Importantly, this was reversed by the central
administration of a JNK inhibitor, implicating hypothalamic
inflammatory pathways in the pathogenesis of obesity and
central insulin resistance (De Souza et al., 2005).
The mechanisms by which consumption of HFD leads to
increased hypothalamic inflammation are not completely under-
stood, but may rely on activation of TLR4. In addition to recog-
nizing LPS, TLR4 can be bound by saturated fatty acids and
invoke an immune response (Fessler et al., 2009; Lee et al.,
2001; Shi et al., 2006; but see Erridge and Samani, 2009), posi-
tioning TLR4 as a physiological sensor of fatty acids. Activation
of TLR4 by fatty acids has been implicated as a key mechanism
linking DIO to increased plasma concentration of inflammatory
markers and insulin resistance in peripheral tissues (Shi et al.,
2006; Tsukumo et al., 2007).
Milanski and colleagues (2009) tested the hypothesis that
hypothalamic TLR4 mediates hypothalamic inflammation in
animals maintained on a HFD, resulting in leptin resistance.
They observed that both HF feeding and direct hypothalamic
infusion of long-chain saturated fatty acids increased hypotha-
lamic cytokine expression and reduced the anorectic response
to leptin. Direct TLR4 loss of function inhibited HFD-induced
inflammation and weight gain and restored leptin sensitivity.
Similarly, Kleinridders et al. (2009) observed that specifically
blocking MyD88-dependent TLR4 activity, by deleting MyD88
selectively in the CNS, leads to reduced HFD intake and DIO,
and restores leptin sensitivity in DIO mice. Although MyD88-
TLR4 inflammatory signaling can signal through both JNK/AP1
and IKKb/NF-kB, the effect of CNS MyD88 to mediate HFD-
induced obesity relies on IKKb signaling, and JNK activity
remained unaltered in these mice (Kleinridders et al., 2009).
Consistent with the possibility that hypothalamic inflammation
contributes to the development of DIO, Zhang et al. (2008)
reported that activation of hypothalamic IKKb/NF-kB increases
in obesity, both in leptin-deficient ob/ob mice fed a chow diet
and in DIO animals. Moreover, acute infusions of glucose or oleic
acid into the brain of fasted mice also increased hypothalamic
IKKb/NF-kB activity, suggesting that an oversupply of nutrientslocally in the brain can drive this inflammatory response. To
specifically test the role of hypothalamic IKKb/NF-kB in DIO,
the authors reduced IKKb activity with virally mediated or consti-
tutive knockdown. Both manipulations reduced HFD intake and
weight gain in DIO animals, whereas increase of hypothalamic
NF-kB activity had the opposite effect. Moreover, increased
hypothalamic NF-kB activity reduced the anorectic action of
insulin and leptin, as well as activation of their downstream-
signaling pathways, PI3K and STAT3 (Zhang et al., 2008).
Providing a critical link, Posey et al. (2009) found that HF feeding
increases the local abundance of saturated long-chain acyl-
CoAs in the hypothalamus, thereby directly connecting the
consumption of HFDwith increased accumulation of intracellular
lipid and activation of inflammatory pathways in the hypothal-
amus. HF feeding was also associated with increased inflamma-
tory signaling via IKKb in this study, and it reduced the
anorectic response to insulin. Hypothalamic insulin sensitivity
was restored by intracerebroventricular administration of an
IKK inhibitor. Importantly, the ability of dietary fat to induce this
inflammatory pathway did not depend on increased total caloric
intake, as rats pair fed the HFD, to the amount of calories
consumed by controls fed a low-fat diet, also had increased acti-
vation of hypothalamic IKKb despite similar caloric intake (Posey
et al., 2009).
One potential link between hypothalamic inflammation and
leptin/insulin resistance is the protein-tyrosine phosphatase-1B
(PTP1B). PTP1B dephosphorylates the insulin- and leptin-
associated Janus kinase (JAK), thereby acting as a negative
regulator of both insulin and leptin signaling (Bourdeau et al.,
2005; Dube´ and Tremblay, 2005). PTP1B is expressed in hypo-
thalamus, where it is increased in HF-fed animals (White et al.,
2009; Zabolotny et al., 2008). Genetic knockdown of PTP1B
in all neurons (Bence et al., 2006), or specifically in neurons
expressing the anorexogenic neuropeptide precursor, proopio-
melanocortin (POMC) (Banno et al., 2010), improves leptin sensi-
tivity and protects against DIO. The mechanism by which PTP1B
is increased by HFD is unclear but may involve inflammatory
signaling pathways. Hypothalamic PTP1B mRNA and protein
are increased during acute TNFa injection. This may depend in
part on activation of NF-kB downstream of TNFa, as PTP1B
appears to be anNFkB target gene. Its promoter contains a puta-
tive NF-kB binding site, and, consistent with this, treatment with
TNFa increases the recruitment of the NFkB subunit p65 to the
PTP1B promoter (Zabolotny et al., 2008). However, although
central administration of TNFa induces leptin and insulin resis-
tance, associated with activation of IKKb, this is not blunted by
knockdown of PTP1B expression with antisense oligonucleo-
tides (Picardi et al., 2010). Consequently, it remains uncertain
whether PTP1B is a critical mediator of HFD-induced leptin
and/or insulin resistance downstream of NF-kB or other inflam-
matory signaling pathways.
Another potential molecular link between hypothalamic
inflammation and leptin/insulin resistance is provided by sup-
pressor-of-cytokine signaling (SOCS) proteins. SOCS proteins
were originally identified as anti-inflammatory, negative regula-
tors of cytokine receptor signaling that inhibit the JAK-
STAT pathway. Activation of STAT transcription factors down-
stream of cytokine receptors is a major source of SOCS
expression, resulting in negative feedback that restrains initialCell Metabolism 15, February 8, 2012 ª2012 Elsevier Inc. 141
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et al., 2008; Thaler and Schwartz, 2010). The leptin receptor is
a member of the class I cytokine receptor family, which includes
the IL-6 receptor and other cytokine receptors (Baumann et al.,
1996; Tartaglia et al., 1995). Signaling through the leptin receptor
drives increased SOCS-3 expression (Bjørbaek et al., 1999). In
turn, SOCS-3 is a negative regulator of leptin signaling and is
thought to contribute to HFD-induced leptin resistance. Mice
deficient in SOCS-3 (Howard et al., 2004) or with brain-specific
SOCS-3 deletion (Mori et al., 2004) are more sensitive to the
anorectic effects of leptin and are resistant to DIO. Hypothalamic
SOCS-3 is increased in DIO, likely the result of both increased
signaling at cytokine receptors in response to low-grade inflam-
mation and increased leptin receptor signaling in response to
rising leptin levels. Consistent with this, SOCS-3 was found to
be a critical mediator of hypothalamic leptin/insulin resistance
downstream of the IKKb/ NF-kB pathway (Zhang et al., 2008).
However, the mechanism by which IKKb was linked to
SOCS-3 in that study is unclear, because no differences in cyto-
kine expression were observed.
Open Questions Regarding the Role of the Innate
Immune Response
Role of Microglia. Despite a growing consensus regarding the
important role of hypothalamic inflammation in the etiology of
DIO, several open questions remain. First, it is not known which
cell types are involved in the initiation of HFD-induced inflamma-
tory responses in hypothalamus (Thaler and Schwartz, 2010). An
important feature of inflamed tissues is macrophage infiltration.
Obesity-associated macrophage infiltration of adipose tissue
has been described in both humans and rodents and contributes
to the emergence and maintenance of low-grade peripheral
inflammation in obesity (Kanda et al., 2006; Weisberg et al.,
2003; Xu et al., 2003). Perhaps analogously, microglial infiltration
of the arcuate nucleus andmedian eminance, but not other brain
regions, is reportedly increased in HFD-fed rats. Moreover the
cellular distribution of TLR4 in hypothalamus occurs primarily
onmicroglia (Milanski et al., 2009), suggesting that hypothalamic
microglial cells may be key to initiating the innate-immune
response to increased abundance of saturated fats. Therefore,
although evidence suggests that IKKb/NF-kB in specific
neuronal populations is critical to HFD-induced inflammation
and participates in the etiology of HFD-induced leptin/insulin
resistance (Zhang et al., 2008), the role of microglia to initiate
this neuronal inflammation remains unclear. Intriguingly, cultured
hypothalamic neurons are resistant to inflammation induced
by saturated fatty acids (Choi et al., 2010), supporting the possi-
bility that communication between microglia and neurons is
necessary for the initiation of HFD-induced hypothalamic
inflammation.
Importance of Various Components of the Inflammatory
Cascade. It also remains unclear which specific components
of the inflammatory cascade are critical to the development of
HFD-induced insulin/leptin resistance. The innate immune
response to HFD includes increased levels of several cytokines
and proinflammatory signaling pathways (De Souza et al.,
2005), making it difficult to identify the relative importance of indi-
vidual components of this response. As discussed above, initial
studies reported that chronic maintenance on a HFD increases
the hypothalamic expression of multiple proinflammatory cyto-142 Cell Metabolism 15, February 8, 2012 ª2012 Elsevier Inc.kines including IL-1b, IL-6, and TNFa, and that both proinflam-
matory cytokine expression and DIO are blunted by loss of
function of TLR4 or JNK, suggesting that cytokine signaling is
a key link between inflammation and diet-induced leptin/insulin
resistance (De Souza et al., 2005; Milanski et al., 2009). In
contrast, other studies observed no change (Kleinridders et al.,
2009; Posey et al., 2009; Zhang et al., 2008) or variable increases
(Oh-I et al., 2010) in cytokine expression with obesity, despite
that activation of hypothalamic IKKb was a critical mediator of
DIO in those studies. These data therefore implicate noncytokine
signaling downstream of NF-kB. Intriguingly, ceramide biosyn-
thesis, which is initiated downstream of IKKb, is essential for
TLR4-dependent insulin resistance in muscle (Holland et al.,
2011). Moreover, after an acute intravenous infusion of lipids,
hypothalamic ceramide concentration is increased in wild-type
but not TLR4-defective mice, and this could be blocked with
systemic administration of the IKK inhibitor, sodium salicylate
(Holland et al., 2011). Collectively, these data suggest the
hypothesis that hypothalamic ceramides might participate in
IKKb-dependent leptin/insulin resistance in the hypothalamus.
Additional studies are needed to directly test this possibility.
Paradoxical Role of Cytokine Signaling in the Regulation of
Energy Balance. The role of proinflammatory cytokine sig-
naling is counterintuitive because these same cytokines are
also important central mediators of illness-induced anorexia
(Asarian and Langhans, 2005; Laye´ et al., 2000; Plata-Salama´n
et al., 1996). It is not clear how a robust, acute, proinflammatory
response to pathogens can elicit reductions in food intake and
body weight, whereas the chronic low-grade proinflammatory
response to fats elicits the opposite response. Thaler and
Schwartz (2010) proposed that this might result from differences
in the affected neuronal populations or in the affected cell types,
where pathogen-provoked immune responses are initiated by
microglia and HFD-induced immune responses are initiated
directly in the neurons (or vice versa). Another possibility is that
HFD-induced obesity results from anti-inflammatory counterre-
gulatory responses, including SOCS-3, rather than reflecting
the inflammation itself. In the case of pathogen-provoked inflam-
mation, anorectic responses to robust cytokine signaling would
result in sickness-induced anorexia that overwhelms any influ-
ence of counter-regulatory responses. On the other hand, in
the case of diet-induced inflammation, although weak cytokine
signaling may be insufficient to drive sickness-anorexia, chronic
anti-inflammatory counter-regulatory responses would provoke
hypothalamic leptin/insulin resistance that leads to higher levels
of defended body weight. In this way the scale and timeframe of
the inflammatory response would predict the outcome with
respect to adiposity.
Endoplasmic Reticulum Stress
The endoplasmic reticulum (ER) may have a key role as a nutrient
sensor (Hotamisligil, 2010) mediating the interaction between
abundance of dietary fat and the defense of a higher body
weight. The ER forms a network of membranes and tubules for
folding, storage, and transport of proteins, assisted bymolecular
chaperone proteins. Increased demand on the ER results in an
imbalancebetweenprotein load and folding capacity, a condition
known as ER stress. ER stress is sensed by the luminal
domains of the transmembrane proteins inositol-requiring-1
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factor 6 (ATF6) to activate a complex response known as the
unfolded protein response (UPR) (Hotamisligil, 2006; Marciniak
and Ron, 2006; Schro¨der and Kaufman, 2005). The UPR restores
the match between ER folding capacity and needs (Bernales
et al., 2006). First, the UPR reduces protein load in the ER by
lowering protein synthesis and increasing clearance. Second,
the increase in UPR target genes, including processing enzymes
and molecular chaperones, results in an increased capacity of
the ER to handle unfolded proteins. Finally, if homeostasis
cannot be re-established by the first two responses, the cell
undergoes apoptosis (Bernales et al., 2006; Ron and Walter,
2007). ER stress has been reported in the liver (Ozcan et al.,
2004) and adipose tissue (Boden et al., 2008) of obese or dia-
betic individuals, and contributes to impaired glucose homeo-
stasis in DIO (Ozcan et al., 2006).
Hypothalamic ER stress is increased in obesity and may
contribute to insulin/leptin resistance in DIO individuals. Acti-
vated PERK is increased in the hypothalamus of DIO (Ozcan
et al., 2009; Zhang et al., 2008) but not diet-resistant (Ozcan
et al., 2009) mice, and this could be blocked by central adminis-
tration of the chemical chaperone, taurine-conjugated urso-
deoxycholic acid (TUDCA) (Zhang et al., 2008). Moreover, acute
treatment with the ER stress-inducing agent tunicamycin
directly into the brain increases hypothalamic expression of the
orexigenic neuropeptides agouti-related peptide (AgRP) and
neuropeptide-Y (NPY) and reduces leptin-induced activation
of STAT3 (Ozcan et al., 2009). To further investigate the role
of ER stress in DIO, mice with a brain-specific knockout of
X-box-binding-protein-1 (XBP1) were challenged with HFD.
Because XBP1, which is activated by IRE1, is a master regulator
of ER folding capacity (Ozcan et al., 2009; Ron andWalter, 2007),
its deletion reduces ER function and thereby reduces the
threshold for induction of the UPR. As anticipated, XNKO mice
were more susceptible to DIO and diet-induced leptin resistance
compared to control mice (Ozcan et al., 2009), suggesting that
ER stress can act as a link between increased dietary fat
consumption, resistance to leptin signaling, and eventually to
the maintenance and defense of greater adiposity (Figure 3).
While these data suggest that the UPR may play a role to
couple obesity and/or nutrient-induced ER stress with leptin
resistance and obesity, important questions remain. First, it will
be important to determine the mechanisms by which ER stress
is increased in DIO. Increased activation of the UPR may be
a consequence of obesity itself, occurring only after chronic
HF feeding and possibly contributing to the maintenance of
obesity, or may result from increased availability of nutrients
preceding weight gain, and thereby contributing to the onset of
obesity. Second, it will be important to understand the down-
stream mechanisms by which ER stress contributes to leptin
and insulin resistance. It appears that inflammatory signaling
through IKKb/ NF-kB may be both upstream (Ozcan et al.,
2009) and downstream (Ozcan et al., 2009; Purkayastha et al.,
2011; Zhang et al., 2008) of the UPR. Intracerebroventricular
administration of TUDCA blunts HFD-induced increases in
NF-kB activity, whereas knockdown of brain IKKb blunts
HFD-induced increases in UPR signaling (Ozcan et al., 2009).
Although it is not clear whether ER stress is initially a conse-
quence or cause of obesity-associated inflammation, thesedata suggest that obesity may create a situation whereby inflam-
mation and ER stress cooperate in a feed-forward manner, re-
sulting in the maintenance of CNS leptin/ insulin resistance in
the presence of HFD.
It is important to note that physiological activation of the UPR
to maintain homeostasis in the ER, as opposed to pathophysio-
logical activation of the UPR leading to apoptosis and cell death,
may be difficult to discriminate on the basis of gene expression
and protein phosphorylation. In light of the available data,
it remains unclear whether homeostatic or apoptotic UPR
pathways (or both) are critical to the observed effects on leptin/
insulin resistance. Specifically, it will be important to determine
whether ER stress-invoked apoptosis occurs in key neuro-
anatomical substrates for leptin and insulin action and, if so,
whether this contributes to the observed outcomes. Recent
evidence suggests that palmitate induces ER stress and
increases apoptosis in a neuronal cell model (Mayer and
Belsham, 2010) and that DIO is associated with increased
apoptosis and reduced synaptic plasticity in the arcuate and
lateral hypothalamic nuclei (Moraes et al., 2009). However, the
extent to which apoptosis results from ER stress in vivo remains
undetermined.
Perspectives on Hypothalamic Leptin and Insulin
Resistance in DIO Animals
To date, most studies investigating mechanisms that link the
consumption of HFD with the defense of greater body adiposity
have focused on molecular aspects of hypothalamic leptin/
insulin resistance. However, the extent to which reduced re-
sponsivity to leptin and insulin is critical to the initiation versus
the maintenance of HFD-induced obesity remains largely
untested (Myers et al., 2010). When an individual is in a stable
environment with abundant food, its homeostatic control system
for body adiposity helps it maintain and defend a particular level
of body fat as discussed above. If the environment is changed in
such a way that the average fat consumption is increased (i.e.,
the individual is put on a HFD, whether voluntarily or not), the
level of fat maintained is often increased andmay lead to obesity.
In this situation, the observed changes in leptin and insulin sensi-
tivity may in fact be secondary, as opposed to causal, to the
entire process. Nonetheless, they may also be necessary for
the obesity to develop since experimental elimination of key
mediators, including those discussed above, precludes the
development of DIO.
Studies investigating mechanisms of diet-induced cellular
hormone resistance typically use a DIO rodent model in which
animals have been maintained on HFD for many weeks. We
therefore know a good deal about how prolonged exposure to
HFD, with its accompanying obesity, modulates cellular
signaling pathways. In contrast, we know much less about the
time course over which these changes develop and what the
precipitating factors might be. In light of this, future studies
that rigorously describe a time course for (1) the development
of insulin and leptin resistance at the level of food intake and
body weight responses, (2) changes in the response of receptor
signaling pathways, and (3) the activation of lipid-sensing
pathways in the hypothalamus, including inflammation and ER
stress, will be informative and should be a priority for future
research.Cell Metabolism 15, February 8, 2012 ª2012 Elsevier Inc. 143
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Figure 4. Vicious Cycle Facilitating Defense of Greater Adiposity
with High-Fat Feeding
Consumption of high-fat foods acts on central reward pathways to elicit further
intake beyond what is necessary to maintain homeostasis. This facilitates
increased nutrient flux to central homeostatic circuits, which leads to cellular
resistance to leptin and insulin. Blunted leptin and insulin signaling results in
reduced sensitivity to satiation signals, and even more food is consumed. In
this way, a feed-forward cycle is created, leading to hyperphagia and obesity.
It is critical to understand the mechanisms by which dietary fats and/or their
metabolites interact with central homeostatic and reward circuitry, as these
represents key targets for therapeutic intervention.
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Despite recent focus on, and the clear importance of, central
resistance to peripheral adiposity signals, this is unlikely to be
the only contributor to defense of greater body adiposity in envi-
ronments characterized by ubiquitous access to high-fat foods.
Many factors can regulate food intake and adiposity, and the
amount of body fat that is ultimately defended probably repre-
sents the integrated effect of diverse factors. Among these is
the hedonic attractiveness of fat; i.e., its pleasurable properties
beyond those derived from caloric content alone. In other words,
one reason that we consume fatty foods is simply because we
enjoy eating them! The pleasurable aspects of fat consumption
derive from both unlearned attraction to orosensory factors
and learned preferences based on postoral factors (Ackroff
and Sclafani, 2010). Both humans (Drewnowski, 1997; Drew-
nowski et al., 1992) and rodents (Imaizumi et al., 2000; Takeda
et al., 2000; Yoneda et al., 2007a, 2007b) have a hedonic prefer-
ence for fat that increases with increasing fat concentration (Fig-
lewicz and Benoit, 2009; Manabe et al., 2010). Moreover, some
fats elicit a conditioned place preference in rodents (Figlewicz
et al., 2004; Imaizumi et al., 2000) and act in a concentration-
dependent manner as a reinforcer under a progressive ratio
schedule operant task (Yoneda et al., 2007b), implying that at
least some dietary fats have both rewarding and reinforcing
properties.
The important question concerns the link between consuming
the HFD and initiating the progression toward obesity and its
associated comorbidities. A corollary question is whether,
when an individual is placed on a HFD, the ensuing obesity is
secondary to modulation of the homeostatic control system, of
the hedonic/reward system, or both. It is clear that hedonics
plays a role, for when an animal is allowed to voluntarily ingest
the HFD, and body weight becomes stable at an elevated level,
homeostatic peptides in the hypothalamus are present at the
same levels as those in stable animals fed a low-fat diet; i.e., in
this condition the homeostatic system is not trying to reduce
body weight. In contrast, if animals are force fed the HFD by
having it put directly into their stomachs each day, they can be
made just as obese as individuals eating the food, but homeo-
static neuropeptide levels indicate that the individual is too
heavy; i.e., orexigenic peptides are decreased and anorexic
peptides are increased relative to controls (Hagan et al., 1999;
Seeley et al., 1996a). Further, once force-feeding ends, the
animals eat little or no food and body weight declines. The differ-
ence seems to be whether the animals experience the hedoni-
cally pleasant aspects of the diet; i.e., whether they voluntarily
taste, chew and swallow it. The important point is that although
both involuntarily overfed and voluntarily overfed individuals
presumably share degrees of dysfunction of lipid-sensing
enzyme cascades, inflammatory cytokines in the plasma and
CNS, ER folding problems, and so on (although this remains to
be tested directly), one is actively attempting to lose weight while
the other is content to remain in the obese state.
The animal freely consuming the HFD activates its hedonic/
reward circuits with every bite. These include corticolimbic
circuits that link the prefrontal cortex, the amygdala, the ventral
tegmental area, the nucleus accumbens, and the ventral pal-
lidum with the medial forebrain bundle. This network, via axonal
circuits, connects the hindbrain and midbrain to key hypotha-144 Cell Metabolism 15, February 8, 2012 ª2012 Elsevier Inc.lamic nuclei involved with homeostatic controls over energy
balance (Cota et al., 2006; Figlewicz and Benoit, 2009; Saper
et al., 2002). What is important is that there is considerable
crosstalk between the homeostatic and non-homeostatic
systems, mediated by in part by direct actions of insulin and
leptin at their receptors within the corticolimbic system, as well
as by secondary hypothalamic effector systems (Davis et al.,
2011a, 2011b; Figlewicz et al., 2001, 2004; Hommel et al.,
2006). These interactions are congruent with a highly integrated
system governing food intake. For example, when an animal is
food deprived, several changes occur. In the homeostatic
circuits, the reduced levels of insulin and leptin act to blunt the
action of satiation signals such that when food is encountered,
the animal will eat larger meals. In the reward circuits, hedoni-
cally pleasing sensations of food become exaggerated (Hommel
et al., 2006). In a word, food tastes better, and this results inmore
food being eaten, even in the face of inhibitory signals from the
gut and adipose tissue.
When a HFD is suddenly made available to an individual,
sensory properties of the food (e.g., odor, taste, mouth feel)
are intrinsically pleasant and lead to more food being consumed.
As this continues, excess calories accumulate as increased
adiposity, and increased circulating fatty acids lead to increased
lipid flux into the brain, insulin/leptin resistance, an inflammatory
condition, and so on. Stated another way, the increased palat-
ability of the diet initiates a vicious cycle in which hedonics cause
more food to be eaten than is necessary to meet energy needs,
and the increased calories in turn initiate events that lead to
insulin/leptin resistance and a consequent tendency to eat
even more food (Figure 4). In this context, it is interesting to
consider how cellular leptin/insulin resistance in key reward
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response to foods. In the same way that reduced leptin and
insulin signaling in the fasted animal exaggerates the hedonic
pleasing sensations of food, so too might blunted leptin and
insulin signaling in DIO exaggerate the pleasurable aspects
of eating, increase the amount of food eaten, and thereby
contribute to this viscous cycle.
Therapeutic Implications
Despite great progress to elucidate central homeostatic path-
ways regulating adiposity, and despite hopeful perspectives
that accompany nearly every new finding, safe and effective
therapies for the treatment of obesity remain elusive. Most indi-
viduals eventually regain adipose tissue that is lost by caloric
restriction, likely because the integrity of the homeostatic system
ismaintained in obesity and thereby drives behavioral and phys-
iological responses to return adipose stores to the prerestricted
(higher) steady state. Evidence suggests that consumption of
hedonically pleasing, calorically dense foods, and particularly
those high in fat content, plays a role to mediate this upward shift
in the defended level of adiposity. Consequently, therapeutic
interventions are needed that target the lipid-sensing and
hedonic mechanisms facilitating this interaction between the
nutritional environment and central homeostatic circuits. In this
way, therapies may be developed that maintain the defense of
a healthy level of adiposity in the face of an obesogenic environ-
ment. Furthermore, themost successful therapies are likely to be
those that target these interactions at multiple nodes to override
the redundancies in the system.
The most effective currently available therapy for obesity is
bariatric surgery. In contrast to individuals that lose a significant
percentage of body fat by caloric restriction only to regain the
weight when the restriction is relieved, individuals that lose
weight with bariatric surgery maintain this lesser adiposity for
many years. This is associated with remarkable improvements
in glucose control and reversal of type-2 diabetes and other
comorbidities (Sjo¨stro¨m et al., 2004). Thus, it appears that bari-
atric surgery may shift the defended level of adiposity, even in
the face of a modern environment characterized by ubiquitous
access to low-cost, HF foods. Despite its efficacy, however,
bariatric surgery is not a practical solution for the large numbers
of individuals now facing obesity and its consequences.
Considerable effort is underway to understand the mechanisms
responsible for changes in defended adiposity following these
procedures, in order to target affected pathways in a less-inva-
sive manner.
Several weight-loss surgeries are currently performed, in-
cluding Roux-en-y gastric bypass (RYGB), vertical sleeve
gastrectomy (VSG), gastric banding (GB), and ileal transposition,
and these encompass varying combinations of gastric restriction
and rerouting of the flow of nutrients through the gut. Contrary to
the widely held belief that a small stomach drives the reduced
food intake, evidence suggests that the therapeutic benefit of
bariatric surgeries may not depend on the restrictive component
of these procedures (Melissas et al., 2007; Stefater et al., 2010).
For example, rats that have recovered from VSG and were
subsequently calorically deprived to produce approximately
30%weight loss can and do overeat and recover their defended
levels of adiposity within the same time frame as sham-operatedcontrols. This outcome indicates that VSG rats could consume
more calories but choose not to (Stefater et al., 2010) and that
their postoperative food intake reflects a new level of defended
adiposity.
Consequently it will be critical to understand how bariatric
surgeries modulate the interactions among HFD, leptin/insulin
sensitivity, the various lipid-sensing pathways described above,
and the hedonic response to eating. Recent data from animal
models indicate that changes in leptin sensitivity may not be
a critical factor leading to weight loss after surgery. In one study
(Stefater et al., 2010), VSG did not improve leptin sensitivity of
DIO rats beyond that achieved by pair-fed controls, and, more-
over, VSG, RYGB, and GB are all effective in obese Zucker
rats, which lack a functional leptin receptor (Lopez et al., 2009;
Xu et al., 2002). On the other hand, the importance of CNS insulin
sensitivity in thesemodels has not yet been tested, and induction
of hypothalamic inflammation or other CNS lipid-sensing path-
ways is unknown. Various satiation signals are increased in
both humans and rodents after RYGB or VSG (Chambers
et al., 2011; Chelikani et al., 2010; Harvey et al., 2010; Peterli
et al., 2009; Shin et al., 2010). The importance of these changes
to facilitate observed metabolic improvements will require
further investigation, and would be definitively addressed by
testing the effects of surgery in various mouse knockout models.
Several studies indicate that the hedonic experience of food is
altered in both humans, who report a reduced drive to eat sweet
and/or fatty foods following bariatric surgery (Olbers et al., 2006;
Thirlby et al., 2006), and rats, which shift their preference from
higher to lower concentrations of oil or sucrose (Shin et al.,
2011). Thus, it seems that bariatric surgeries can interfere with
the relationship between physiology and the modern nutritional
environment in several ways, providing a permanent combina-
tion therapy that leads to the defense of lesser adiposity.
The key point here is that successful therapeutic intervention
for the large population facing the social, financial and health
consequences of obesity will depend on understanding both
(1) how consumption of calorically dense high-fat diets in-
creases the defended level of adiposity and (2) how effective
therapies manage to disrupt CNS mechanisms underlying this
change in defended body weight, including HFD-induced
leptin/insulin resistance. Such an endeavor will ultimately require
a systems approach involving a variety of disparate disciplines
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